New Variants. New Boosters. But So Far, No New COVID Spending From Congress
Consider This from NPR
NPR
4.2 • 6.2K Ratings
🗓️ 29 March 2022
⏱️ 10 minutes
🧾️ Download transcript
Summary
But against that backdrop, Congress has so far refused to authorize more COVID spending measures, which would fund the stockpiling of more vaccine doses and public health surveillance for emerging variants.
NPR's Selena Simmons-Duffin reports on the funding debate. NPR's Michaeleen Doucleff looks at another variant whose creation gives scientists insight into how COVID-19 variants change, and why.
In participating regions, you'll also hear a local news segment to help you make sense of what's going on in your community.
Email us at considerthis@npr.org.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Transcript
Click on a timestamp to play from that location
| 0:00.0 | So yeah, about this new COVID sub variant, it's called a BA2. |
| 0:06.3 | Right now, BA2 is becoming the majority of the virus population in the US. |
| 0:12.1 | What that means is that we're going to see a bump in infections. |
| 0:15.0 | Bill Hanage is an epidemiologist and a professor at Harvard. |
| 0:18.5 | BA2 is why case rates are inching back up in places like LA, and Chicago over 20% of the |
| 0:28.6 | cases in Midwestern states and Boston. |
| 0:31.5 | BA2 is now causing more than half of new cases in the Northeast, including here in Massachusetts. |
| 0:36.9 | The expectation from public health officials is just like in many European countries, |
| 0:41.6 | BA2 will soon become the dominant variant here. |
| 0:45.5 | But right now, it doesn't look like BA2 is much more serious in terms of the disease |
| 0:50.1 | of causes. |
| 0:51.3 | Of course, protection from that disease depends on prior infection, vaccination, or both. |
| 0:58.5 | The thing is, protection, it wanes over time. |
| 1:02.5 | So, on Tuesday, the Food and Drug Administration authorized use of a second booster dose of |
| 1:07.8 | Pfizer and Moderna for any American over the age of 50, or for certain people who are immunocompromised. |
| 1:14.9 | That fourth dose, it can be given four months after an initial booster. |
| 1:19.0 | However, if the science shows that fourth doses are needed for the general population later this year, |
| 1:24.7 | we will not have the supply necessary to ensure sorts are available, free and easy, |
| 1:30.6 | to access for all Americans. |
| 1:32.4 | That's Jeff Zines at the White House COVID Task Force. |
| 1:35.3 | He issued a warning this past week. |
| 1:37.9 | We should be securing additional supply right now. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

